286 related articles for article (PubMed ID: 34078402)
21. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
23. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
24. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
25. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
[TBL] [Abstract][Full Text] [Related]
26. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
[TBL] [Abstract][Full Text] [Related]
27. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
28. Uncovering the pathogenesis and identifying novel targets of pancreatic cancer using bioinformatics approach.
Zhao LL; Zhang T; Zhuang LW; Yan BZ; Wang RF; Liu BR
Mol Biol Rep; 2014 Jul; 41(7):4697-704. PubMed ID: 24728565
[TBL] [Abstract][Full Text] [Related]
29. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
30. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the Lipid Droplet-Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties.
Kuramoto K; Yamamoto M; Suzuki S; Togashi K; Sanomachi T; Kitanaka C; Okada M
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33466690
[TBL] [Abstract][Full Text] [Related]
32.
Deng Y; Ma H; Hao J; Xie Q; Zhao R
Biomed Res Int; 2020; 2020():8604340. PubMed ID: 32420375
[TBL] [Abstract][Full Text] [Related]
33. Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.
Jin Y; Tan Y; Chen L; Liu Y; Ren Z
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400205
[TBL] [Abstract][Full Text] [Related]
34. Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancer.
He C; Jiang H; Geng S; Sheng H; Shen X; Zhang X; Zhu S; Chen X; Yang C; Gao H
Int J Clin Exp Pathol; 2012; 5(6):537-46. PubMed ID: 22949936
[TBL] [Abstract][Full Text] [Related]
35. The Expression Levels of Vinculin in Pancreatic Cancer Tissues Significantly Correlates With Patient Survival.
Islam S; Kitagawa T; Azuma T; Kuramitsu Y
Anticancer Res; 2021 Oct; 41(10):4979-4984. PubMed ID: 34593445
[TBL] [Abstract][Full Text] [Related]
36. Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile.
Wang B; Sun S; Liu Z
Mol Biol Rep; 2014 Jul; 41(7):4361-7. PubMed ID: 24619357
[TBL] [Abstract][Full Text] [Related]
37. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
38. Expression of AGPAT2, an enzyme involved in the glycerophospholipid/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia.
Triantafyllou EA; Georgatsou E; Mylonis I; Simos G; Paraskeva E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1142-1152. PubMed ID: 29908837
[TBL] [Abstract][Full Text] [Related]
39. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.
Xu Q; Fu R; Yin G; Liu X; Liu Y; Xiang M
Gene; 2016 Mar; 578(2):263-73. PubMed ID: 26719042
[TBL] [Abstract][Full Text] [Related]
40. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
